Defibrillator News and Research

Latest Defibrillator News and Research

Boston Scientific provides new warranty program for CRT-D device to avoid phrenic nerve stimulation

Boston Scientific Corporation today announced that it is offering a new warranty program in the U.S. that covers its cardiac resynchronization therapy defibrillator devices and leads in the event of chronic phrenic nerve stimulation.

6 May 2011

CAMH presents new Microvolt T-wave Alternans testing data at Heart Rhythm Society meeting

Cambridge Heart, Inc. a developer of non-invasive diagnostic tests for cardiac disease, today announced that new data presented at the Heart Rhythm Society's 32nd Annual Scientific Sessions in San Francisco confirm the diagnostic value of Microvolt T-wave Alternans testing in identifying patients at risk of sudden cardiac arrest.

6 May 2011

Man with no pulse for 96 minutes makes complete recovery

By all counts, the 54-year-old man who collapsed on a recent winter night in rural Minnesota would likely have died. He'd suffered a heart attack, and even though he was given continuous CPR and a series of shocks with a defibrillator, the man was without a pulse for 96 minutes.

6 May 2011

Cameron Health completes enrollment in subcutaneous implantable defibrillator pivotal study

Cameron Health, Inc. announced today that it has completed enrollment in its pivotal FDA clinical study of the S-ICD System, the world's only completely subcutaneous implantable defibrillator.

5 May 2011

First implantation of WiCS wireless cardiac pacing system performed in Germany

EBR Systems, Inc., a privately held clinical stage company, announced today the first human implants of the WiCS Wireless Cardiac Stimulation System.

3 May 2011

WAST NHS to equip its frontline ambulances with ZOLL E Series EMS monitor/defibrillator

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that the Welsh Ambulance Services NHS is equipping its frontline ambulances with the ZOLL E Series EMS monitor/defibrillator.

30 Apr 2011

ZOLL Medical second quarter revenues increase 14% to $122.5 million

ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions, today announced that revenues for the second quarter of fiscal 2011 increased 14% to $122.5 million, compared to revenues in the second quarter of last year of $107.1 million.

28 Apr 2011

FDA approves BIOTRONIK's new Estella and Effecta pacemakers

BIOTRONIK, a leading manufacturer of implantable cardiac devices and pioneer of wireless remote monitoring technologies, today announced FDA approval of the new Estella and Effecta pacemakers, as well as advanced new features and technologies for the Evia pacemaker family.

28 Apr 2011

Cardiac Science receives European contract for automated external defibrillator

The wholly-owned subsidiary of Opto Circuits Ltd., Cardiac Science Corporation, a global leader in automated external defibrillator and diagnostic cardiac monitoring devices, has been awarded a contract to deploy 650 Powerheart AEDs in Girona, Spain, home to 700,000 Catalonians.

27 Apr 2011

Spectranetics revenue increases 5% to $30.4 million for first quarter 2011

Spectranetics Corporation today reported financial results for the quarter ended March 31, 2011.

27 Apr 2011

Canada Prime Minister announces $10 million fund for defibrillators and related training

Today Prime Minister Stephen Harper announced a $10 million plan to fund life-saving automated external defibrillators and related training in hockey arenas and community recreation centres across Canada.

22 Apr 2011

Experts question hospital's heart device data claims

The New York Times: Medical Experts Dispute A Hospital's Claims On Heart Device Data.

22 Apr 2011

First Edition: April 21, 2011

In today's news, reports about President Barack Obama's Facebook visit during which he stepped up his criticism of GOP plans to overhaul Medicare and Medicaid but said he expects to strike a deal to reduce the deficit.

21 Apr 2011

Forest acquires worldwide rights to novel antiarrhythmic agent azimilide

Forest Laboratories, Inc. today announced that its wholly-owned subsidiary Forest Laboratories Holdings Limited and Blue Ash Therapeutics, LLC have entered into an asset purchase agreement, pursuant to which Forest has acquired worldwide rights to azimilide, a novel antiarrhythmic agent originally developed by Procter & Gamble Pharmaceuticals.

20 Apr 2011

Japanese MHLW approves Spectranetics LLD lead locking device

Spectranetics Corporation today announced that the Japanese Ministry of Health, Labor and Welfare granted approval for the LLD lead locking device, which is used for the removal of pacemaker and defibrillator cardiac leads.

6 Apr 2011

ICD therapy can improve ischemic cardiomyopathy survival rates

Most patients with ischemic cardiomyopathy and dilated cardiomyopathy who have an implantable cardioverter-defibrillator now live more than seven years and those ICD patients with hereditary heart disease can live for decades, based on a scientific paper that will be presented at the American College of Cardiology Scientific Sessions in New Orleans, April 1-3.

6 Apr 2011

Heart patients share perspectives on deactivation, donation and reuse of ICD devices

Each year, more than 100,000 patients in the U.S. undergo implantation of a new implantable cardioverter defibrillator (ICD) for heart rhythm abnormalities. This number constitutes a 20-fold increase over the last 15 years. Current medical guidelines advocate discussion of end of life care of these medical devices, including deactivation, but many patients may not understand their options.

6 Apr 2011

Defibrillator News and Research

Latest Defibrillator News and Research

Boston Scientific provides new warranty program for CRT-D device to avoid phrenic nerve stimulation

CAMH presents new Microvolt T-wave Alternans testing data at Heart Rhythm Society meeting

Man with no pulse for 96 minutes makes complete recovery

Cameron Health completes enrollment in subcutaneous implantable defibrillator pivotal study

First implantation of WiCS wireless cardiac pacing system performed in Germany

WAST NHS to equip its frontline ambulances with ZOLL E Series EMS monitor/defibrillator

ZOLL Medical second quarter revenues increase 14% to $122.5 million

FDA approves BIOTRONIK's new Estella and Effecta pacemakers

Cardiac Science receives European contract for automated external defibrillator

Spectranetics revenue increases 5% to $30.4 million for first quarter 2011

Canada Prime Minister announces $10 million fund for defibrillators and related training

Experts question hospital's heart device data claims

First Edition: April 21, 2011

Forest acquires worldwide rights to novel antiarrhythmic agent azimilide

Japanese MHLW approves Spectranetics LLD lead locking device

ICD therapy can improve ischemic cardiomyopathy survival rates

Heart patients share perspectives on deactivation, donation and reuse of ICD devices

Adherence to guideline-related therapies can reduce heart failure patients' mortality rate

FDA approves Medtronic's Protecta implantable defibrillators

FDA approves Medtronic's Consulta and Syncra pacemaker systems

Innovation in neuroscience drug discovery - eBook eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Defibrillator News and Research

Latest Defibrillator News and Research

Innovation in neuroscience drug discovery - eBook eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Newsletters you may be interested in